Prevalence of compounding in independent community pharmacy practice

Journal of the American Pharmacists Association

Volumn 46, Issue 5, 2006, Pages 568-573

  McPherson, Timothy B ^a   Fontane, Patrick E ^b   Jackson, Kelsey D ^b   Martin, Kathleen S ^c   Berry, Tricia ^b   Chereson, Rasma ^b   Bilger, Rhonda ^b  

^a SOUTHERN ILLINOIS UNIVERSITY EDWARDSVILLE   (United States)

^b ST LOUIS COLLEGE OF PHARMACY   (United States)

^c UNIVERSITY OF THE INCARNATE WORD   (United States)

Author keywords

Community and ambulatory pharmacies; Compounding; Survey

Indexed keywords

ARTICLE; CONTROLLED STUDY; DRUG FORMULATION; HEALTH SERVICE; HUMAN; MEDICAL PRACTICE; PATIENT CARE; PHARMACEUTICAL CARE; PHARMACIST; PHARMACY; PRESCRIPTION; PREVALENCE; QUESTIONNAIRE; CROSS-SECTIONAL STUDY; FEMALE; MALE; STATISTICS;

COMMUNITY PHARMACY SERVICES; CROSS-SECTIONAL STUDIES; DRUG COMPOUNDING; FEMALE; HUMANS; MALE;

EID: 33750731311     PISSN: 15443191     EISSN: 15443450     Source Type: Journal    
DOI: 10.1331/1544-3191.46.5.568.McPherson     Document Type: Article

References (16)

1. Anonymous. Model state pharmacy act and model rules of the National Association of Boards of Pharmacy, June 2003. Accessed at www.nabp.net. May 13, 2005.
2. DeNuzzo RV. Annual prescription survey by the Albany College of Pharmacy. Med Mark Media. 1975;10:12-8.
3. DeNuzzo RV. 20th annual prescription survey by the Albany College of Pharmacy. Med Mark Media. 1976;11:17-34.
4. DeNuzzo RV. Annual prescription survey by the Albany College of Pharmacy. Med Mark Media. 1978;13:17-37.
5. DeNuzzo RV. 24th annual prescription survey Albany College of Pharmacy. Med Mark Media. 1980;15:17-36.
6. DeNuzzo RV. 26th Albany Rx survey: Tylenol with codeine leads the way. Med Mark Media. 1982;17:36-66.
7. Schommer JC, Doucette WR, Mott DA. Prescription compounding in Wisconsin pharmacies. Wise Pharm. 1990;59(Dec):24-5.
8. Federal and state role in pharmacy compounding and reconstitution: exploring the right mix to protect patients. Hearing before the Senate committee on Health, Education, Labor, and Pensions, 108th Cong., 1st Sess. (2003) (statement of Janet Heinrich, Director, Health Care-Public Health Issues. Prescription drugs: state and federal oversight of drug compounding by pharmacies).
9. IACP Web site. Accessed at www.iacprx.org, June 3, 2005.
10. Federal and state role in pharmacy compounding and reconstitution: exploring the right mix to protect patients. Hearing before the Senate committee on Health, Education, Labor, and Pensions, 108th Cong., 1st Sess. (2003) (statement of Steven K Galson, Acting Director Center for Drug Evaluation and Research, U.S. FDA). Accessed at www.fda.gov/ola/2003/pharmacycompound1023.html, June 13, 2005.
11. Subramaniam V, Sokol G, Zenger V, et. al. Survey of drug products compounded by a group of community pharmacies: findings from a Food and Drug Administration study. Accessed at www.fda.gov/cder/pharmcomp/communityPharmacy/ default.htm, May 15, 2005.
12. Centers for Disease Control and Prevention. Exophiala infection from contaminated injectable steroids prepared by a compounding pharmacy-United States, July-November 2002. MMWR Morb Mortal Wkly Rep. 2002;51(49):1109-12.
13. IACP Foundation Potency Task Force Web page. Accessed at www.iacprx.org/potencytaskforce/background.htm, June 13, 2005.
14. Anonymous. Missouri Board of Pharmacy News. May 2005;23(2):1.
15. NCPA-Pfizer digest. Alexandria, Va.: National Community Pharmacists Association; 2004.
16. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533-43.